ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) addresses the need of patients, physicians, payers, regulators, and manufacturers to improve the affordability and accessibility to innovative health technologies (including pharmaceuticals) in Europe.



ASCERTAIN is a project aimed at helping people get better access to new health technologies such as medicines, medical devices, and tests. The project is creating a tool that can be used by decision-makers to understand the cost and value of these new health technologies.

What is the ASCERTAIN policy support tool?

The tool will be accessible to everyone on the internet and will have information about the cost and value of these new health technologies. It will also consider the impact on the environment. The project will work with patients, industry, policy makers, and payers to make sure the tool is good quality and useful.

Why is the affordability of innovative health technologies a challenge?

It’s a challenge for many countries in the European Union to afford new health technologies because they are often expensive and not everyone has equal access to them. This tool will help decision-makers understand how much these technologies should cost and how much they can save the healthcare system.

What are the goals of ASCERTAIN?

The goal of ASCERTAIN is to make it easier for people to understand the cost and value of new health technologies. The tool will be open to everyone and will be able to be adapted to different countries’ needs. It will have information about the cost and value of these technologies and will encourage “greener” production.



Recent site visits have highlighted the dynamic and collaborative efforts of the ASCERTAIN project in advancing precision cancer medicine (PCM) and health technology assessments (HTA) in Norway.

On April 12th, PhD student Yansi Wu presented initial findings from our Structured Expert Elicitation (SEE) project to the CONNECT group, a consortium focused on overcoming...
Read more

Greener pharmaceuticals: policies for an environmentally sustainable pharmaceutical system

The webinar on greener pharmaceuticals, hosted by the Pharmacoeconomics Department at Gesundheit Österreich, emphasized the role of pharmaceuticals in transitioning towards a planetary health approach. The event explored policy measures like health technology assessment and public procurement of medicines to promote sustainable health systems. It drew...
Read more

"Everyone is entitled to the best treatment, no matter where you live"

In many countries, patients have to wait a long time before expensive medicine become available, reducing their chance of survival. This is unfair and has to change, says professor of Health Technology Assessment Carin Uyl-de Groot at Erasmus School of Health Policy &...
Read more

Discussion in the Health Committee of the House of Representatives (Belgium Federal Parliament) was granted to Solidaris (a member of the consortium partner AIM) this week following Solidaris’s citizen initiative for a fair price for medicines compiling more than 50,000 signatures.

Solidaris very successfully presented its bill for fair drug prices as several parties immediately...
Read more

The recent EAA Spring Convention, themed 'Finding the Right Balance,' held at Erasmus Universiteit Rotterdam, brought together industry experts and stakeholders to explore the complexities of navigating the European Union's market access for medicines and devices. Co-organized by ASCERTAIN alongside Maureen Rutten-van Mölken, Joerg Ruof, and Elaine Julian, the convention delved into key issues surrounding Health Technology Assessment...
Read more

Dear readers,

Six months have passed since our last newsletter, and a lot has happened.

In this second issue of the ASCERTAIN newsletter, we are pleased to present an interview with Maria Piggin, founder and chair of the PNH Global Alliance. Maria Piggin talks...
Read more

A catalyst for collaborative advances in cancer immunotherapy

On 16th of February, Dr Frederick Thielen represented ASCERTAIN at the 6th European CAR T-cell Meeting. His journey began by attending the meeting of the T2EVOLVE consortium, an EU-funded initiative pioneering collaboration between leading scientists and industry in cancer immunotherapy. This ground-breaking alliance aims to...
Read more

Navigating Challenges in Health Economics and Outcomes Research

Last week, Carin Uyl-de Groot, Mirjana Huić, Nicolas Xander and Isabelle Durand-Zaleski presented ASCERTAIN in Copenhagen. Their session was entitled: "Horizon Europe Project Ascertain: Supporting a sustainable and transparent EU HTA regulatory framework, accessibility of innovative technologies and health equity".

In this session,...
Read more

Dear Readers, 

The affordability of newly approved innovative health technologies (IHTs) is challenging in many health systems. Health care payers and health care industry across the European Union (EU) have explored different ways of defining payment for new products. ASCERTAIN addresses the need of patients, physicians, payers, regulators,...
Read more

From: iMTA NEWSLETTER September 2023

With deep sorrow we share the heartbreaking news of the loss of our dear colleague, Margreet Franken. Margreet started her professional career as a nurse, specialised in coronary and intensive care nursing. Over the years, she held various positions in hospitals located in Arnhem, Rotterdam, and Christchurch (New Zealand)....
Read more



ESMO Congress 2024

The ESMO Congress is a globally influential oncology platform for clinicians, researchers, patient advocates, journalists and healthcare industry representatives from all over the world.
ESMO 2024 will disseminate the latest cutting-edge data, provide high quality education and excellent networking opportunities for oncologists and other stakeholders from all around the world.

The innovative, LIVE Plus Congress format will offer participants the option to attend in person, in Barcelona or online, through the Virtual Congress Platform, from 13-17 September 2024.

Join partners in Barcelona!

Click here for more information.

Click here to see the program.


ISPOR Europe 2024

Join global healthcare leaders as they convene at ISPOR Europe 2024, the leading global conference in Europe for Health Economics and Outcomes Research (HEOR), 17 -20 November, for discussion and dissemination of the latest trends in healthcare. This must-attend event provides you with dedicated opportunities to network with your peers, HEOR experts, and thought leaders and to discuss with a global audience how we establish, incentivize, and share value sustainable for health systems, patients, and technology developers.

Join partners in Barcelona!

Click here for more information.

Click here to see the program.


Discover how ASCERTAIN is tackling inequalities in access to healthcare technologies with our latest animated video! Learn about the project’s mission to improve affordability and sustainability while promoting innovation and considering environmental impacts.


Please get in touch with us if you have any questions or comments! We will get back to you as soon as possible.

For research-related questions:

Carin Uyl-de Groot
Project Coordinator

Erasmus University Rotterdam
Phone: +31 10 4081583

For general project questions:

Marcel Langone Marques
Project Manager

Erasmus University Rotterdam
Phone: +31 10 4081583

For communications:

Lena Jessen
Project Manager

Phone: +49 40 226211490

Our Partners